Estrella Immunopharma Cash Flow Statement 2021-2024 | ESLA

Fifteen years of historical annual cash flow statements for Estrella Immunopharma (ESLA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212021
$-7.31$-11.11$-1.00$-0.25$0.00
$0$0$0$0$0.00
$1.19$0.41$-0.62$0.00$0
$1.19$0.41$-0.62$0.00$0
$0$0$0$0$0
$0$0$0$0$0
$-9.33$8.39$0$0$0
$-0.15$0.83$0.13$-0.14$0
$-9.95$9.37$0.58$-0.07$0.00
$-16.07$-1.34$-1.04$-0.32$0.00
$0$0$0$0$0.00
$0$0$0$0$0
$0$0$0$0$0.00
$0$0$0$0$0
$0$0$36.17$-45.19$0
$0$0$36.17$-45.19$-3.19
$4.96$-0.27$0$0$0
$4.96$-0.27$36.17$-45.19$-3.19
$-5.07$0$0.05$0$0
$0$0$0.50$0$0.18
$-5.07$0$0.55$0$0.00
$-0.35$0$-36.11$47.45$0
$8.67$0$-36.11$47.45$0.03
$0$0$0$0$0.00
$9.20$0$0$-1.47$0
$12.79$0$-35.56$45.98$0.21
$1.69$-1.61$-0.44$0.48$-2.99
$1.19$0.41$0$0$0
$0$0$0$0$0